Evidence map›Paper›PMID 30261354›Full record

ArticleEpilepsy research2018

Ketogenic diet regulates the antioxidant catalase via the transcription factor PPARγ2.

Sara Knowles, Sarah Budney, Malavika Deodhar, Stephanie A Matthews, Kristina A Simeone, Timothy A Simeone

Abstract read
In one paragraph

Article in Epilepsy research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. The Ketogenic Diet Revisited: Beyond Ketones.Frontiers in neurology · 2021
    Article
  9. Article
  10. Review
  11. Nutrients · 2020
    Review
  12. Induced Ketosis as a Treatment for Neuroprogressive Disorders: Food for Thought?The international journal of neuropsychopharmacology · 2020
    Review
  13. Review
  14. Article
  15. Recent Advances in Epilepsy.Current neuropharmacology · 2019
    Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Sara KnowlesCreighton University, School of Medicine, Department of Pharmacology, Omaha, NE, 68174, USA.
Sarah BudneyCreighton University, School of Medicine, Department of Pharmacology, Omaha, NE, 68174, USA.
Malavika DeodharCreighton University, School of Medicine, Department of Pharmacology, Omaha, NE, 68174, USA.
Stephanie A MatthewsCreighton University, School of Medicine, Department of Pharmacology, Omaha, NE, 68174, USA.
Kristina A SimeoneCreighton University, School of Medicine, Department of Pharmacology, Omaha, NE, 68174, USA.
Timothy A SimeoneCreighton University, School of Medicine, Department of Pharmacology, Omaha, NE, 68174, USA. Electronic address: timothysimeone@creighton.edu.
Creighton University · US

Funding

PPARgamma, Epilepsy and TherapeuticsR01NS085389 · NINDS · CREIGHTON UNIVERSITY · PI SIMEONE, TIMOTHY A. · 2014 to 2018
$1.5M
Adenosine, Hypocretin and Sleep Disorder Comorbidities Associated with EpilepsyR01NS072179 · NINDS · CREIGHTON UNIVERSITY · PI SIMEONE, KRISTINA A · 2012 to 2016
$1.5M
Replacing an Animal Resource Facility Cage Washer.G20RR024001 · NCRR · CREIGHTON UNIVERSITY · PI DRESCHER, KRISTEN · 2007 to 2007
$638k
NCRR NIH HHS G20 RR024001NINDS NIH HHS R01 NS072179NINDS NIH HHS R01 NS085389
6 · The paper itself

Abstract

We have previously found that the transcription factor PPARγ2 contributes to the mechanism of action of the ketogenic diet (KD), an established treatment for pediatric refractory epilepsy. Among the wide-array of genes regulated by PPARγ, previous studies have suggested that antioxidants such as catalase may have prominent roles in KD neuroprotective and antiseizure effects. Here, we tested the hypothesis that the KD increases catalase through activation of PPARγ2, and that this action is part of the mechanism of antiseizure efficacy of the KD. We determined catalase mRNA and protein expression in hippocampal tissue from epileptic Kcna1

Indexed as

Diet, KetogenicAnimalsCatalaseConvulsantsDisease Models, AnimalEnzyme InhibitorsGene Expression RegulationHippocampusKv1.1 Potassium ChannelMiceMice, Inbred C57BLMice, TransgenicPentylenetetrazolePPAR gammaRNA, MessengerSeizuresCatalaseConvulsantsEnzyme InhibitorsKcna1 protein, mouseKv1.1 Potassium ChannelPentylenetetrazolePPAR gammaRNA, MessengerSodium AzideEpilepsyIn vivoMetabolismPeroxisome proliferator activated receptorPPARPPARgamma

Identifiers

PMID30261354
PMCPMC6192850
OpenAlexW2893594848

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.